Serum institute of india
Sep 19, 2020 20:06
Around 150 to 200 volunteers will be administered the vaccine candidate dose in Pune’s Sasson General Hospital read more
Sep 19, 2020 06:21
The Central Drugs Standard Control Organisation (CDSCO) has granted test license permission for manufacture of Covid-19 vaccine for preclinical test, examination and analysis to the seven manufacturers in India. read more
Sep 18, 2020 17:59
The Central Drugs Standard Control Organization has not received any report regarding any deviation from the standard procedures in research and development of Covid-19 vaccine. read more
Sep 17, 2020 09:18
The Covid-19 recovery rate has further improved to 78.53 per cent, the health ministry said on Wednesday. Twenty-seven states and union territories are reporting recovery rates of more than 70 per cent, it highlighted. read more
![“The permission has been given to restart the trials with certain conditions,” said a senior official aware of the developments in the DCGI office, asking not to be named. The conditions include ‘extra care during screening, additional information [for] informed consent and close monitoring for similar events during the study follow-up’.](https://www.hindustantimes.com/rf/image_size_300x200/HT/p2/2020/09/17/Pictures/outbreak-pune-the-coronavirus-disease-covid-19_7414bf96-f878-11ea-b206-fe77f4f0660e.jpg "SII gets DCGI approval to resume Covid-19 vaccine trials")
Sep 16, 2020 23:52
“The permission has been given to restart the trials with certain conditions,” said a senior official aware of the developments in the DCGI office, asking not to be named. The conditions include ‘extra care during screening, additional information [for] informed consent and close monitoring for similar events during the study follow-up’. read more
Sep 16, 2020 08:28
The DCGI, however, put certain conditions like taking extra care during screening, providing additional information in informed consent and close monitoring for adverse events during follow-up of the study which have to be “scrupulously” followed by Serum Institute of India (SII). read more
Sep 16, 2020 07:40
In August, the US drugmaker had signed a deal with the Serum Institute of India, the world’s largest producer of vaccines, to produce a minimum of one billion doses of its vaccine candidate. read more
Sep 15, 2020 16:07
The WHO has praised AstraZeneca’s decision to put its vaccine trials on hold, while Chinese official says vaccine may be available for public use in November 2020. read more
Sep 15, 2020 14:47
Economic damage from Covid-19 is reinforcing inequalities, and extreme poverty has increased by 7% read more
Sep 14, 2020 18:42
Adar Poonawalla’s remarks came a day after Union health minister Harsh Vardhan said a vaccine against the coronavirus disease would be ready by early next year. read more
Sep 13, 2020 11:16
AstraZeneca, one of the frontrunners in this endeavour, received a setback when the trial of its vaccine candidate was paused.The trials have now been resumed and the world is waiting with bated breath to how the vaccines will be delivered to them. read more
Sep 12, 2020 21:37
Good news, tweets Serum Institute of India CEO Adar Poonawalla, after Astrazeneca announced it has got a go-ahead from British regulators. read more
Sep 12, 2020 07:42
Earlier this week, AstraZeneca said it had paused the trials because of ‘an unexplained illness’ in a participant in the study. read more
Sep 10, 2020 15:40
UK-based pharma giant AstraZeneca paused vaccine trials after one of the recipients in the United Kingdom developed an ‘unexplained illness’ after being given a dose of the vaccine. read more
Sep 09, 2020 23:54
Drugs Controller General of India Dr V G Somani has asked SII why the permission granted for conducting phase 2 and 3 clinical trials of the vaccine candidate in the country should not be suspended till patient safety is established. read more
